BIO Related Press Releases
-
Bio-Rad Named One of the 'Best Places to Work 2013' in the San Francisco Bay Area
-
BioAlliance Pharma announces DSMB second positive recommendation to continue its Phase III clinical trial with Livatag® in primary liver cancer
-
Bio-Rad Reports First-Quarter 2013 Financial Results
-
BioAlliance Pharma Updates on Major Achievements of 2012 and Publishes Its 2012 Consolidated Financial Statements and Income for Q1 2013
-
BioAlliance Pharma’s Sitavig® Receives Market Authorization in the US For the Treatment of Herpes Labialis
-
Bio-Rad to Report First-Quarter 2013 Financial Results Tuesday, May 7, 2013
Back to BIO Stock Lookup
